SCHEMBL27912729

SCHEMBL27912729

O=C(NCC1CN(c2ccc(-n3ccccc3=O)cc2)C(=O)O1)c1cccs1

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 19/20 0.69
▸ MAOB P27338 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27870563 0.86 F10 (0.69) F10
SCHEMBL27853868 0.86 F10 (0.69) F10
SCHEMBL27853867 0.86 F10 (0.69) F10
SCHEMBL30387893 0.85 F10 (0.56) F10
SCHEMBL27853869 0.84 F10 (0.80) F10
SCHEMBL27853870 0.84 F10 (0.80) F10
SCHEMBL27870561 0.84 F10 (0.69) F10
SCHEMBL27870562 0.84 F10 (0.69) F10
SCHEMBL16234736 0.84 F10 (0.80) F10
SCHEMBL78345 0.82 F10 (1.00) F10MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104163819-A Acetic acid solvate of oxazolidinone derivative, and preparation method and use thereof TIANJIN INST PHARM RESEARCH 2014-11-26 — — CN claimed
CN-103242307-A Crystal form I of oxazolidinone derivative as well as preparation method and application of crystal form I TIANJIN INST PHARM RESEARCH 2013-08-14 — — CN claimed
CN-103232446-A Oxazolidinone derivative crystal form II and preparation method and application thereof TIANJIN INST PHARM RESEARCH 2013-08-07 — — CN claimed
CN-103242307-A Crystal form I of oxazolidinone derivative as well as preparation method and application of crystal form I TIANJIN INST PHARM RESEARCH 2013-08-14 — — CN disclosed
CN-103232446-A Oxazolidinone derivative crystal form II and preparation method and application thereof TIANJIN INST PHARM RESEARCH 2013-08-07 — — CN disclosed
Send feedback